JW Therapeutics competitorsClear all
Neovii's top competitors include Eutilex.
 Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
|  Eutilex Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology. | |
Founding Date | Founding Date 2003 | Founding Date 2015 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US | Locations KR HQ |
Employees | Employees 89 | Employees 108 |
For sources of this data, please see the company profile
View company profiles
Eutilex
HQ
KR
Employees
108
Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology.
View company